CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i
Considering Mycological Rarities
-
September 2021
-
Source: Emerg Infect Dis. 27(9):2510-2511
Details:
-
Alternative Title:Emerg Infect Dis
-
Personal Author:
-
Description:Mattia di Nanni di Stefano (1403–1433), Scipio Africanus ca. 1425–1430. Poplar, bog oak and other wood inlay, rosewood, tin, bone, traces of green coloring, 24.19 in x 17.13 in/61.5 cm x 43.3 cm. Public domain image courtesy of The Metropolitan Museum of Art, New York, NY, USA.
Neither plant nor animal, fungal organisms―in- cluding lichen, mildew, mushrooms, molds, rusts, smuts, and yeasts―are found in nearly every possible terrestrial habitat, even aboard the Interna- tional Space Station. There are millions of species of fungi, and according to the Centers for Disease Con- trol and Prevention, a few hundred fungal species cause illness in people, ranging from allergies and asthma, to skin rashes and infections, to deadly infec- tions of the bloodstream or lungs.
In a 2013 EID article, Mary Brandt and Benjamin Park note the growing number of human infections from traditional and new fungal agents. Factors driv- ing this emergence, they explain, include medical treatments that make immunocompromised patients more susceptible. They also state that “Risk factors such as changes in land use, seasonal migration, inter- national travel, extreme weather, and natural disas- ters, and the use of azole antifungal agents in large- scale agriculture are believed to underlie many of the increases in community-acquired fungal infections.”
The recent emergence of Candida auris infections, for instance, underscores those concerns on a broad scale because C. auris is often multidrug-resistant, dif- ficult to identify, and causes outbreaks in healthcare settings. A recent study from Finland that reported life-threatening fungal bloodstream infections associ- ated with consuming probiotic supplements that con- tain Saccharomyces boulardii reveals a route of infection that may represent another mycological issue.
-
Subjects:
-
Source:
-
Pubmed Central ID:PMC8386784
-
Document Type:
-
Volume:27
-
Issue:9
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: